Value in health
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 631
-
Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO ConsortiumByrom, Bill / Watson, Chris / Doll, Helen et al. | 2018
- 640
-
Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus SurveyThorn, Joanna C. / Brookes, Sara T. / Ridyard, Colin et al. | 2018
- 650
-
Agreement among the Productivity Components of Eight Presenteeism Tests in a Sample of Health Care WorkersThompson, Angus H. / Waye, Arianna et al. | 2018
- 658
-
A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United KingdomWilson, Edward C.F. / Usher-Smith, Juliet A. / Emery, Jon et al. | 2018
- 669
-
Expert Elicitation of Multinomial Probabilities for Decision-Analytic Modeling: An Application to Rates of Disease Progression in Undiagnosed and Untreated MelanomaWilson, Edward C.F. / Usher-Smith, Juliet A. / Emery, Jon et al. | 2018
- 677
-
A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness AnalysesLevy, Joseph / Rosenberg, Marjorie / Vanness, David et al. | 2018
- 685
-
Cost-Effectiveness Analysis of a Navigation Program for Colorectal Cancer Screening to Reduce Social Health Inequalities: A French Cluster Randomized Controlled TrialDe Mil, Rémy / Guillaume, Elodie / Guittet, Lydia et al. | 2018
- 692
-
State Medicaid Reimbursement for Medications for Chronic Hepatitis C Infection from 2012 through 2015Lu, Christine Y. / Zhang, Fang / Golonski, Nicole et al. | 2018
- 698
-
Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in GermanyIsbary, Georg / Staab, Thomas R. / Amelung, Volker E. et al. | 2018
- 707
-
Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder PerceptionsWang, Ting / McAuslane, Neil / Liberti, Lawrence et al. | 2018
- 715
-
Experiences of Structured Elicitation for Model-Based Cost-Effectiveness AnalysesSoares, Marta O. / Sharples, Linda / Morton, Alec et al. | 2018
- 724
-
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood ChallengePalmer, Andrew J. / Si, Lei / Tew, Michelle et al. | 2018
- 732
-
Evaluation of Split Version and Feedback Module on the Improvement of Time Trade-Off DataWong, Eliza L.Y. / Shah, Koonal / Cheung, Annie W.L. et al. | 2018
- 742
-
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute WorkshopKluetz, Paul G. / Kanapuru, Bindu / Lemery, Steven et al. | 2018
- 748
-
Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with AsthmaGray, Laura A. / Hernández Alava, Mónica / Wailoo, Allan J. et al. | 2018
- A1
-
Table of Contents| 2018
-
Copyright/Subscription| 2018
-
Editorial Board| 2018
-
C2: Editorial board PU 21/5| 2018